Publication Feature: Developing and Adopting Safe and Effective Digital Biomarkers to Improve Patient Outcomes

March 2019

This review, published in Nature Digital Medicine, discusses considerations for development and evaluation of digital biomarkers, as well as the context in which they are frequently being applied. The authors are Andy Coravos, research collaborator at the Harvard-MIT CRS, Sean Khozin, Director of FDA INFORMED, and Ken Mandl, Director of Boston Children’s Computational Health Informatics Program. Learn more here.